LivingGLP1
Study S002350

Functional Impact of GLP-1 for Heart Failure Treatment

Registration

Registration
NCT01800968
Acronym
FIGHT
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
DOUBLE
Status
COMPLETED
Enrollment
300
Start
2013-04
Primary completion
2015-10
Lead sponsor
Duke University
Conditions
Acute Heart Failure
Interventions
DRUG:Liraglutide; DRUG:Placebo
Results posted
TRUE
Secondary identifiers
NIH:5U10HL084904-09

Registered primary outcomes

  • Global Ranking of Predefined Events [Randomization to 180 days]

Linked records (5)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0020428Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes.
Lerman JB, Scientific reports
2022Randomized trialPMID 35654972DOIcites ClinicalTrials.gov:NCT01800968; registry reference DERIVED:35654972
R0023961Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.
Redouane B, Circulation. Heart failure
2020Randomized trialPMID 32362166DOIcites ClinicalTrials.gov:NCT01800968; registry reference DERIVED:32362166
R0024780Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.
Sharma A, ESC heart failure
2018Randomized trialPMID 30120812DOIcites ClinicalTrials.gov:NCT01800968; registry reference DERIVED:30120812
R0021603Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Margulies KB, JAMA
2016Randomized trialPMID 27483064DOIcites ClinicalTrials.gov:NCT01800968; registry reference DERIVED:27483064
R0049420Diabetes, Impaired Fasting Glucose, and Heart Failure: Its not All About the Sugar
Abhinav Sharma, European Journal of Heart Failure
2014Nonrandomized studyPMID 25315254DOIcites ClinicalTrials.gov:NCT01800968